Puzo Michael J reduced its holdings in shares of Danaher Corporation (NYSE:DHR – Free Report) by 2.2% in the 2nd quarter, Holdings Channel.com reports. The fund owned 46,469 shares of the conglomerate’s stock after selling 1,038 shares during the period. Danaher makes up approximately 2.6% of Puzo Michael J’s portfolio, making the stock its 21st largest position. Puzo Michael J’s holdings in Danaher were worth $9,179,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in DHR. Patriot Financial Group Insurance Agency LLC boosted its holdings in shares of Danaher by 7.2% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 1,067 shares of the conglomerate’s stock valued at $219,000 after buying an additional 72 shares during the last quarter. Capital Investment Advisors LLC boosted its holdings in shares of Danaher by 28.8% in the 1st quarter. Capital Investment Advisors LLC now owns 7,267 shares of the conglomerate’s stock valued at $1,490,000 after buying an additional 1,627 shares during the last quarter. Courier Capital LLC boosted its holdings in shares of Danaher by 77.3% in the 1st quarter. Courier Capital LLC now owns 3,733 shares of the conglomerate’s stock valued at $765,000 after buying an additional 1,627 shares during the last quarter. Portside Wealth Group LLC boosted its holdings in shares of Danaher by 12.4% in the 1st quarter. Portside Wealth Group LLC now owns 1,004 shares of the conglomerate’s stock valued at $206,000 after buying an additional 111 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its holdings in shares of Danaher by 12.0% in the 1st quarter. Farther Finance Advisors LLC now owns 8,719 shares of the conglomerate’s stock valued at $1,747,000 after buying an additional 935 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insider Buying and Selling at Danaher
In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 11.20% of the company’s stock.
Danaher Trading Down 1.5%
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter last year, the firm earned $1.72 earnings per share. The company’s revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 27.23%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the company. Wells Fargo & Company cut their price objective on Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a report on Wednesday, July 23rd. Evercore ISI increased their price objective on Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a report on Tuesday. Royal Bank Of Canada set a $241.00 price objective on Danaher in a report on Tuesday, September 2nd. Robert W. Baird raised their price target on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a report on Friday, July 18th. Finally, Redburn Partners set a $220.00 price target on Danaher in a report on Wednesday. Seventeen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $245.63.
View Our Latest Stock Analysis on Danaher
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Financial Services Stocks Investing
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- 3 Fintech Stocks With Good 2021 Prospects
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- Insider Trading – What You Need to Know
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.